tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tandem Diabetes Care: Strategic Initiatives and Market Challenges Justify Hold Rating
PremiumRatingsTandem Diabetes Care: Strategic Initiatives and Market Challenges Justify Hold Rating
1M ago
Tandem Diabetes assumed with an Outperform at Oppenheimer
Premium
The Fly
Tandem Diabetes assumed with an Outperform at Oppenheimer
1M ago
Tandem announces Health Canada authorization for t:slim mobile application
Premium
The Fly
Tandem announces Health Canada authorization for t:slim mobile application
1M ago
Arm initiated, Adobe downgraded: Wall Street’s top analyst calls
PremiumThe FlyArm initiated, Adobe downgraded: Wall Street’s top analyst calls
2M ago
Tandem Diabetes downgraded to Hold from Buy at Lake Street
Premium
The Fly
Tandem Diabetes downgraded to Hold from Buy at Lake Street
2M ago
Tandem Diabetes price target lowered to $51 from $53 at Barclays
Premium
The Fly
Tandem Diabetes price target lowered to $51 from $53 at Barclays
2M ago
Tandem Diabetes price target lowered to $24 from $59 at Canaccord
PremiumThe FlyTandem Diabetes price target lowered to $24 from $59 at Canaccord
2M ago
Tandem Diabetes announces medical device correction for t:slim X2 insulin pumps
Premium
The Fly
Tandem Diabetes announces medical device correction for t:slim X2 insulin pumps
2M ago
Tandem Diabetes downgraded to Hold from Buy at Nephron Research
Premium
The Fly
Tandem Diabetes downgraded to Hold from Buy at Nephron Research
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100